FDA Approves Saphnelo™ as New Treatment for Lupus
FDA Approves Saphnelo™ as New Treatment for Lupus The U.S. Food and Drug Administration (FDA) has approved Saphnelo™ (anifrolumab-fnia) as a treatment for adults with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy. Saphnelo is the third therapy for lupus to receive regulatory approval since 2011. Developed by AstraZeneca, Saphnelo is…